Article
Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Leukemia research - 1 Dec 2016
Burnworth Bettina, Wang Zhixing, Singleton Timothy P, Bennington Angela, Fritschle Wayne, Bennington Richard, Brodersen Lisa Eidenschink, Wells Denise A, Loken Michael R, Zehentner Barbara K
Abstract excerpt
MYD88 L265P, a diagnostic marker for lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM) can also be detected in other hematopoietic malignancies. We demonstrate a novel approach to increase the specificity of this marker for WM/LPL diagnosis by combining flow cytometric cell sorting with molecular analysis. Clonal B-lymphocyte and co-occurring clonal plasma cell populations of low-grade B-cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
